PS-B06-11: GLUCAGON-LIKE PEPTIDE-1 SUPPRESSES ACTIVATED EFFECTOR MEMORY T CELL SUBSETS IN THE FATTY LIVER INDUCED BY ANTI-CD3-ADNTIBODY ADMINISTRATION IN LEAN MICE. (January 2023)
- Record Type:
- Journal Article
- Title:
- PS-B06-11: GLUCAGON-LIKE PEPTIDE-1 SUPPRESSES ACTIVATED EFFECTOR MEMORY T CELL SUBSETS IN THE FATTY LIVER INDUCED BY ANTI-CD3-ADNTIBODY ADMINISTRATION IN LEAN MICE. (January 2023)
- Main Title:
- PS-B06-11: GLUCAGON-LIKE PEPTIDE-1 SUPPRESSES ACTIVATED EFFECTOR MEMORY T CELL SUBSETS IN THE FATTY LIVER INDUCED BY ANTI-CD3-ADNTIBODY ADMINISTRATION IN LEAN MICE
- Authors:
- Itoh, Arata
Yuki, Kazunari
Irie, Junichiro
Itoh, Hiroshi - Abstract:
- Abstract : Objective: We previously invented a disease-model of hepatosteatosis, glucose tolerance and hyperlipidemia, typically observed in non-alcoholic fatty liver disease with metabolic syndrome, but without obesity, through activation of CD4-positive lymphocytes by anti-CD3 antibody administration in lean mice. We also showed that this model is CD4 T-cell dependent and glucagon-like-protein-1 receptor agonist reduces cytokine production in the liver with amelioration of fatty liver, hyperglycemia and hyperglycemia in this model. The precise mechanisms, however, remains unclear. We investigated how GLP-1RA targets and suppresses T cells. Design and Method: GLP-1R expression on activated T cell subsets in the liver and spleen was analyzed using flow-cytometry one day after administration of anti-CD3 antibody in the female lean Balb/c mice. Purified splenic CD4 T cells were differentiated into Th1, Th2, Th17 or regulatory T cells in-vitro and glp1r gene expression and GLP-1R protein expression were analyzed with real-time PCR and flow-cytometry, respectively. Results: anti-CD3 antibodies significantly increased GLP-1R+ CD62L- CD44+ effector-memory CD4 and CD8 T cells in the liver and GLP-1RA protected from increasing number of those CD4 and CD8 T cells in the liver in vivo. Activated and in-vitro induced Th1, Th2, Th17 and regulatory T cell subsets expresses express GLP-1R. Conclusions: GLP-1RA targets activated/effector-memory T cell subsets and reduces theirAbstract : Objective: We previously invented a disease-model of hepatosteatosis, glucose tolerance and hyperlipidemia, typically observed in non-alcoholic fatty liver disease with metabolic syndrome, but without obesity, through activation of CD4-positive lymphocytes by anti-CD3 antibody administration in lean mice. We also showed that this model is CD4 T-cell dependent and glucagon-like-protein-1 receptor agonist reduces cytokine production in the liver with amelioration of fatty liver, hyperglycemia and hyperglycemia in this model. The precise mechanisms, however, remains unclear. We investigated how GLP-1RA targets and suppresses T cells. Design and Method: GLP-1R expression on activated T cell subsets in the liver and spleen was analyzed using flow-cytometry one day after administration of anti-CD3 antibody in the female lean Balb/c mice. Purified splenic CD4 T cells were differentiated into Th1, Th2, Th17 or regulatory T cells in-vitro and glp1r gene expression and GLP-1R protein expression were analyzed with real-time PCR and flow-cytometry, respectively. Results: anti-CD3 antibodies significantly increased GLP-1R+ CD62L- CD44+ effector-memory CD4 and CD8 T cells in the liver and GLP-1RA protected from increasing number of those CD4 and CD8 T cells in the liver in vivo. Activated and in-vitro induced Th1, Th2, Th17 and regulatory T cell subsets expresses express GLP-1R. Conclusions: GLP-1RA targets activated/effector-memory T cell subsets and reduces their proliferation and cytokine production. … (more)
- Is Part Of:
- Journal of hypertension. Volume 41(2023)Supplement 1
- Journal:
- Journal of hypertension
- Issue:
- Volume 41(2023)Supplement 1
- Issue Display:
- Volume 41, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 41
- Issue:
- 1
- Issue Sort Value:
- 2023-0041-0001-0000
- Page Start:
- e369
- Page End:
- Publication Date:
- 2023-01
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://journals.lww.com/jhypertension/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004872-000000000-00000 ↗
http://www.jhypertension.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/01.hjh.0000916564.38258.29 ↗
- Languages:
- English
- ISSNs:
- 1473-5598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5004.510000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26438.xml